Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week

Bristol, Amgen, Teva CEOs among execs to testify at House drug pricing hearings next week

Source: 
Fierce Pharma
snippet: 

Current and former executives from Celgene, Bristol Myers Squibb, Teva, Amgen, Mallinckrodt and Novartis will testify next Wednesday and Thursday on pricing and competition in the drug industry. The committee has also said it'll subpoena AbbVie about Imbruvica and Humira, two pricey megablockbusters protected by dozens of patents.